Formation Bio is a tech-driven, AI-native pharmaceutical company that is revolutionizing the drug development process. By leveraging a proprietary technology-driven platform, Formation Bio aims to bring new treatments to patients faster and more efficiently, addressing critical unmet patient needs across various therapeutic areas. The company acquires clinical-stage drugs from pharma, universities, and biotech sectors and develops them more efficiently, using AI and technology to navigate the traditional bottlenecks in drug development. With a focus on radical efficiency, safety, and quality, Formation Bio seeks to bridge the gap between scientific discovery and patient access to new treatments.